Related references
Note: Only part of the references are listed.Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks
Shunheng Zhou et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Integrative Analysis of Multi-Genomic Data for Kidney Renal Cell Carcinoma
Ashwinder Singh et al.
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2020)
Tumour angiogenesis and c-Met pathway activation - implications in breast cancer
Suvradeep Mitra et al.
APMIS (2020)
Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction
Dharambir Kashyap et al.
LIFE SCIENCES (2020)
RNA-Seq-Based Breast Cancer Subtypes Classification Using Machine Learning Approaches
Zhezhou Yu et al.
COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE (2020)
RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer
Fei Chen et al.
JOURNAL OF BIOMEDICAL RESEARCH (2020)
Cancer Statistics, 2020: Report From National Cancer Registry Programme, India
Prashant Mathur et al.
JCO GLOBAL ONCOLOGY (2020)
Immunohistochemical expression of cyclin D1 in invasive breast carcinoma and its correlation with clinicopathological parameters
Pranoti Vitthalrao Lengare et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2020)
Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer
Soo Youn Bae et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2020)
Molecular Mechanisms of Action of Tocotrienols in Cancer: Recent Trends and Advancements
Vaishali Aggarwal et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma
Jing-ping Li et al.
MEDICINE (2019)
Correlation of p16 Expression on Cancer and Stromal Cells With Clinicopathologic and Immunohistochemical Features of Lobular Breast Carcinoma
Aparna Harbhajanka et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2019)
MDM2, MDM2-C, and mutant p53 expression influence breast cancer survival in a multiethnic population
Lenora W. M. Loo et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
RNA-seq from archival FFPE breast cancer samples: molecular pathway fidelity and novel discovery
Nathan D. Pennock et al.
BMC MEDICAL GENOMICS (2019)
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours
Arian Lundberg et al.
BREAST CANCER RESEARCH (2019)
Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression
Mustapha Abubakar et al.
NPJ BREAST CANCER (2019)
Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential
Dharambir Kashyap et al.
MOLECULAR DIAGNOSIS & THERAPY (2018)
Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
Mihriban Karaayvaz et al.
NATURE COMMUNICATIONS (2018)
Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype
Su Yeon Lee et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng et al.
GENES & DISEASES (2018)
PVT1 affects EMT and cell proliferation and migration via regulating p21 in triple-negative breast cancer cells cultured with mature adipogenic medium
Lingli Wang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer A meta-analysis
Xi Sun et al.
MEDICINE (2017)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
Yunbao Pan et al.
PLOS ONE (2017)
Epigenetic Determinants of Cancer
Stephen B. Baylin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
Ji-Yeon Kim et al.
CANCER RESEARCH AND TREATMENT (2016)
Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer
Ann H. Rosendahl et al.
CLINICAL CANCER RESEARCH (2015)
Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics
Mary E. Law et al.
MOLECULAR PHARMACOLOGY (2015)
Tumor-suppressor Genes, Cell Cycle Regulatory Checkpoints, and the Skin
Ana Maria Abreu Velez et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2015)
Topology and Control of the Cell-Cycle-Regulated Transcriptional Circuitry
Steven B. Haase et al.
GENETICS (2014)
Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters
Gayatri Ravikumar et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
Fisetin: A Dietary Antioxidant for Health Promotion
Naghma Khan et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
p53 in breast cancer subtypes and new insights into response to chemotherapy
Philippe Bertheau et al.
BREAST (2013)
Control of cell cycle transcription during G1 and S phases
Cosetta Bertoli et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Molecular regulation of stem cell quiescence
Tom H. Cheung et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
p21CIP1 mediates reciprocal switching between proliferation and invasion during metastasis
X. Qian et al.
ONCOGENE (2013)
P16 and P53 Play Distinct Roles in Different Subtypes of Breast Cancer
Ming Shan et al.
PLOS ONE (2013)
Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer
Zuoren Yu et al.
NATURE COMMUNICATIONS (2013)
The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis
P. Yang et al.
SCIENTIFIC REPORTS (2013)
p16 expression correlates with basal-like triple-negative breast carcinoma
Amany A. Abou-Bakr et al.
ECANCERMEDICALSCIENCE (2013)
Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion
Meiou Dai et al.
BREAST CANCER RESEARCH (2013)
Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
Jueng Soo You et al.
CANCER CELL (2012)
Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance NUPR1 and p21 in chemoresistance
Andrew J. Vincent et al.
FEBS LETTERS (2012)
Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer
Yoshimi Arima et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
Alan S. Coates et al.
BREAST CANCER RESEARCH (2012)
A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion
Meiou Dai et al.
BREAST CANCER RESEARCH (2012)
Regulatory Mechanisms of Tumor Suppressor P16INK4A and Their Relevance to Cancer
Junan Li et al.
BIOCHEMISTRY (2011)
p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)
Jonathan F. Lara et al.
CLINICAL CANCER RESEARCH (2011)
Examining the role of cyclin D1 in breast cancer
Marco A. Velasco-Velazquez et al.
FUTURE ONCOLOGY (2011)
Clinical Implication of p53 Overexpression in Breast Cancer Patients Younger than 50 Years with a Triple-negative Subtype Who Undergo a Modified Radical Mastectomy
Dong-Soo Lee et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Electromagnetically induced transparency in strongly interacting Rydberg gases
C. Ates et al.
PHYSICAL REVIEW A (2011)
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients
Maurizio Scaltriti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian women
Vinayak W. Patil et al.
BREAST CANCER-TARGETS AND THERAPY (2011)
Nitric Oxide Synthase Expression and Functional Response to Nitric Oxide Are Both Important Modulators of Circulating Angiogenic Cell Response to Angiogenic Stimuli
Christian Heiss et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Cyclin D1/Cyclin-Dependent Kinase 4 Interacts with Filamin A and Affects the Migration and Invasion Potential of Breast Cancer Cells
Zhijiu Zhong et al.
CANCER RESEARCH (2010)
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort
E. Nimeus-Malmstrom et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
p27Kip1 as a prognostic factor in breast cancer: a systematic review and meta-analysis
Xiaoxiang Guan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Cell cycle and cell death in disease: past, present and future
B. Zhivotovsky et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Roles for Growth Factors in Cancer Progression
Esther Witsch et al.
PHYSIOLOGY (2010)
Oncogenes and Tumor Suppressor Genes
Eva Y. H. P. Lee et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Predictive and prognostic molecular markers for cancer medicine
Sunali Mehta et al.
Therapeutic Advances in Medical Oncology (2010)
High cyclin B1 expression is associated with poor survival in breast cancer
K. Aaltonen et al.
BRITISH JOURNAL OF CANCER (2009)
Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy
Martin Filipits et al.
CLINICAL CANCER RESEARCH (2009)
Tumor Suppressive Functions of p53
Jack T. Zilfou et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol
Ilija Androic et al.
BMC CANCER (2008)
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy
Margaretha Rudas et al.
CLINICAL CANCER RESEARCH (2008)
G1 to S phase cell cycle transition in somatic and embryonic stem cells
Irina Neganova et al.
JOURNAL OF ANATOMY (2008)
CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome
Somaia Elsheikh et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
p27Kip1 and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy
Peggy L. Porter et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to nucleus in mouse hepatocarcinogenesis
Masahiro Yamamoto et al.
MOLECULAR CARCINOGENESIS (2006)
p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation
Dennis Sohn et al.
CANCER RESEARCH (2006)
Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells
Robin L. Kilker et al.
CANCER RESEARCH (2006)
Prognostic impact of Skp2 and p27 in human breast cancer
Frank Traub et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function
Chenguang Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients
AM Sieuwerts et al.
CLINICAL CANCER RESEARCH (2006)
Cell cycle control in breast cancer cells
CE Caldon et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer
P Poikonen et al.
BRITISH JOURNAL OF CANCER (2005)
Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification
K Jirström et al.
CANCER RESEARCH (2005)
Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells
YH Joung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2005)
Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance
M Ahnström et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Cyclins and cdks in development and cancer: a perspective
A Deshpande et al.
ONCOGENE (2005)
Cyclin E in normal and neoplastic cell cycles
HC Hwang et al.
ONCOGENE (2005)
p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor α
A Fritah et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells
RL Kilker et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
P27kip1 down-regulation is associated with trastuzumab resistance in breast cancer cells
R Nahta et al.
CANCER RESEARCH (2004)
Cyclins and breast cancer
RL Sutherland et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2004)
p27 deregulation in breast cancer: Prognostic significance and implications for therapy
A Alkarain et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2004)
Oncogenes and tumor suppressor genes in breast cancer: Potential diagnostic and therapeutic applications
C Osborne et al.
ONCOLOGIST (2004)
Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells
I Brown et al.
BREAST CANCER RESEARCH (2004)
Expression of p27kip I in breast cancer and its prognostic significance
A Barnes et al.
JOURNAL OF PATHOLOGY (2003)
High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin
G Pohl et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer
S Han et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27Kip and p21Cip
WJ Chen et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Prognostic value of p53 molecular status in high-risk primary breast cancer
P Marchetti et al.
ANNALS OF ONCOLOGY (2003)
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status -: Results from International Breast Cancer Study Group Trial V
VJ Spataro et al.
CANCER (2003)
Cyclin E and survival in patients with breast cancer.
K Keyomarsi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The cyclin D1 high and cyclin E high subgroups of breast cancer:: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node
M Lodén et al.
ONCOGENE (2002)
High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas - Relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors
M Kouvaraki et al.
CANCER (2002)
AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival
Y Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients
Y Umekita et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
R Michalides et al.
BRITISH JOURNAL OF CANCER (2002)
Subcellular localisation of cyclin B, Cdc2 and p21WAF1/CIP1 in breast cancer:: association with prognosis
ZE Winters et al.
EUROPEAN JOURNAL OF CANCER (2001)
Akt-dependent phosphorylation of p21Cip1 regulates PCNA binding and proliferation of endothelial cells
L Rössig et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
P21/WAF1/Cip1 expression in invasive ductal breast carcinoma: relationship to p53, proliferation rate, and survival at 5 years
W Domagala et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2001)
p27 expression correlates with short-term, but not with long-term prognosis in breast cancer
M Leivonen et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Correlation of p27 protein expression with HER-2/neu expression in breast cancer
L Newman et al.
MOLECULAR CARCINOGENESIS (2001)
Expression of cell-cycle regulator p27 is correlated to the prognosis and ER expression in breast carcinoma patients
T Nohara et al.
ONCOLOGY (2001)
Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications
R Donnellan et al.
HUMAN PATHOLOGY (2001)
A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence
JS Carroll et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Activation of the estrogen-signaling pathway by p21WAF1/CIP1 in estrogen receptor-negative breast cancer cells
XM Chen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells
S Cariou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
